Spring has sprung, which means it’s hay fever season. From shutterstock.comNearly one in five Australians are affected by hay fever. If you’re one of the unlucky ones, you’ll know how troublesome the symptoms can be.
Grass pollen is the major outdoor trigger of hay fever and allergic asthma. Pollen grains contain a variety of allergens that can trigger allergic reactions in people who are sensitised to pollen.
The good news is, if pollen is a problem for you, there are things you can do to manage your exposure to it. By adopting some simple tips alongside preventative medications, you may find this hay fever season a little more manageable.
What causes hay fever?
People who are genetically prone to develop allergies may become sensitised to pollen.
Sensitisation involves development of specific antibodies (called Immunoglobulin E, or IgE) that can bind to the triggering allergen. Repeated exposure to the triggering allergen leads to the activation of inflammatory cells, causing the release of histamine and other mediators. That’s when the symptoms kick in.
An allergic reaction to pollen can lead to hay fever symptoms affecting the upper airways, including itchy, watery eyes, an itchy, inflamed throat, a runny or blocked nose, and sneezing.
Pollen allergy can also lead to what we call allergic asthma – if the allergen components enter deeper into the lungs, this can cause inflammation and symptoms of asthma, like shortness of breath.
While hay fever has long been regarded a trivial condition, it can be a serious chronic disease associated with other problems such as sinusitis, sleep disturbance because of nasal blockage, and asthma, leading to fatigue and poor performance at work or school.
What can you do to reduce exposure to pollen allergens?
The tragic thunderstorm asthma epidemic of November 2016 in Melbourne shocked many and elucidated the potential harm of grass pollen exposure.
Lessons from this event illustrate staying indoors with the windows closed reduces risk of experiencing severe symptoms.
Many people affected by thunderstorm asthma recall being outside prior to the passage of the thunderstorm across the greater Melbourne region during the late evening of November 21, 2016.
Of course, this was an uncommon event, and the majority of people who get hay fever will not experience this level of illness.
On high pollen days, or after thunderstorms in spring, people who are allergic to pollen should stay inside with windows closed when possible. They should also drive with the car windows closed and the air on a setting where it’s circulating, rather than coming in from outside.
Other actions people can take to reduce allergen exposure are to hang washing inside or use a tumble dryer on high pollen days, avoid activities such as mowing the lawn, wear sunglasses outdoors, and shower after activities likely to involve pollen exposure.
A national standardised pollen monitoring network
For people with hay fever, knowing when the pollen count is likely to be high can be helpful in managing exposure. There are an increasing number of mobile apps you can use to monitor the pollen count in your area in real time.
In 2016, the National Health and Medical Research Council funded the AusPollen Partnership. Since its inception, and with the efforts of many researchers, a national standardised pollen monitoring network is being established to help address unmet needs of patients with hay fever and allergic asthma in our community.
The AusPollen Partnership seeded the growth of a number of projects in which pollen monitoring is a key activity; for instance AirRater in Tasmania and VicTAPS in Victoria. Australian pollen monitoring sites now adopt standard protocols to harmonise pollen monitoring processes so data is comparable between locations.
While expanding the pollen monitoring network, we’ve had the opportunity to evaluate how providing people with local, current daily pollen information helps.
In a pilot study, we found people who didn’t have access to local pollen information indicated a desire to have local pollen information, while people who did have access to pollen information reported it was very useful. Respondents used pollen information to plan their daily activities, to minimise pollen exposure and to optimise medication use.
Preventative medication has an important role
While minimising exposure to pollen may help reduce symptoms when pollen levels are high, the cornerstone to symptom management and safety during the pollen season is preventative medication like steroid nasal sprays and antihistamines. These can reduce the underlying allergic inflammation and alleviate symptoms of hay fever.
Before the onset of the pollen season, people who are allergic to pollen and suffer from troublesome symptoms should start using medications daily. Control of underlying allergic inflammation in the upper airways is best achieved with nasal sprays containing a topically active steroid. Non-sedating antihistamine tablets and eye drops provide symptom relief (but don’t alter the underlying inflammation).
Seasonal asthma and/or thunderstorm asthma can occur during the grass pollen season in some people with pollen allergy. Those who experience lower airway symptoms during the grass pollen season such as a cough, tight chest, breathlessness or wheeze, should seek medical attention to consider whether they have undiagnosed asthma.
Read more: Thunderstorm asthma: who’s at risk and how to manage it
This article was co-authored by:
and
Disclosure statement
Janet Davies receives funding from The National Health and Medical Research Council, Australian Research Council, National Foundation for Medical Research Innovation, Emergency Medicine Foundation, Bureau of Meteorology, Victorian Department of Health and Human Services as well as co-sponsorship from Abionic Switzerland, Stallergenes Australia, Asthma Australia iwth in kind co-contributions from Australasian Society for Clinical Immunology and Allergy, CSIRO, Bureau of Meteorology,and Federal Office of Meteorology and Climatology MeteoSwiss, Switzerland. She is an inventor of patents assigned to QUT granted in Australia, allowed in USA and two applications pending examination. Prof. Davies’s institute has received Honorarium payments and travel expenses for education sessions and conference presentations from Stallergenes Australia, GlaxoSmithKliene, Wymedical, and Meda Pharmaceuticals.
Connie Katelaris is a principal investigator on an NHMRC partnership grant for AusPollen Partnership. Dr Katelaris is also principal investigator on clinical trials in severe allergic asthma sponsored by Sanofi and Novartis. She receives honorarium for advisory board participation in Seqirus.
This article is a syndicated news item via 
